Immunic, Inc.IMUXNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average, slight contraction.
Left:
||||
Year-over-year operating income growth rate
Latest
4.02%
↑ 133% above average
Average (39q)
-12.29%
Historical baseline
Range
High:78.85%
Low:-274.48%
CAGR
-4.0%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 4.02% |
| Q2 2025 | -0.96% |
| Q1 2025 | -4.66% |
| Q4 2024 | 0.37% |
| Q3 2024 | -12.76% |
| Q2 2024 | 4.47% |
| Q1 2024 | -2.14% |
| Q4 2023 | 0.80% |
| Q3 2023 | 5.80% |
| Q2 2023 | 8.18% |
| Q1 2023 | 52.46% |
| Q4 2022 | -184.98% |
| Q3 2022 | 2.40% |
| Q2 2022 | 3.85% |
| Q1 2022 | 1.32% |
| Q4 2021 | -18.13% |
| Q3 2021 | 4.08% |
| Q2 2021 | 40.81% |
| Q1 2021 | -128.24% |
| Q4 2020 | -4.76% |
| Q3 2020 | -10.82% |
| Q2 2020 | -35.59% |
| Q1 2020 | -10.11% |
| Q4 2019 | 10.80% |
| Q3 2019 | 38.85% |
| Q2 2019 | -57.09% |
| Q1 2019 | -274.48% |
| Q4 2018 | 78.85% |
| Q3 2018 | 6.60% |
| Q2 2018 | 10.87% |
| Q1 2018 | 1.95% |
| Q4 2017 | -16.94% |
| Q3 2017 | -0.72% |
| Q2 2017 | 1.09% |
| Q1 2017 | -7.29% |
| Q4 2016 | -15.49% |
| Q3 2016 | -7.26% |
| Q2 2016 | 1.14% |
| Q1 2016 | 2.37% |
| Q4 2015 | 19.82% |